BIOMERICA INC Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
BIOMERICA INC (BMRA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $6.56 per share for the 12-month period ending 2025-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-31
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2018-08-31 was $0.83, a 20.19% decline year-over-year.
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2017-08-31 was $1.04.
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2015-08-31 was $0.42, a 10.53% increase year-over-year.
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2014-08-31 was $0.38, a 0.00% change year-over-year.
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $6.56.
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $1.73, a 13.07% decline from fiscal 2022.
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $1.99.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 1 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|---|
| 2025-05-31 | $6.56 10-K · filed 2026-08-31 | ||||
| 2025-02-28 | $0.82 10-Q · filed 2025-04-14 | ||||
| 2023-05-31 | $1.73 10-K · filed 2024-08-28 | ||||
| 2023-02-28 | $1.73 10-Q · filed 2023-04-14 | ||||
| 2022-11-30 | $1.73 10-Q · filed 2023-01-13 | ||||
| 2022-05-31 | $1.99 10-K · filed 2023-08-25 | ||||
| 2022-02-28 | $1.71 10-Q · filed 2022-04-14 | ||||
| 2019-02-28 | $0.77 10-Q · filed 2019-04-15 | ||||
| 2018-11-30 | $0.77 10-Q · filed 2019-01-14 | ||||
| 2018-08-31 | $0.83 10-Q · filed 2018-10-15 | ||||
| 2018-02-28 | $0.78 10-Q · filed 2018-04-16 | ||||
| 2017-11-30 | $0.75 10-Q · filed 2018-01-17 | ||||
| 2017-08-31 | $1.04 10-Q · filed 2017-10-16 | ||||
| 2017-02-28 | $0.46 10-Q · filed 2017-04-14 | ||||
| 2016-11-30 | $0.43 10-Q · filed 2017-01-17 | ||||
| 2016-02-29 | $0.41 10-Q · filed 2016-04-14 | ||||
| 2015-11-30 | $0.44 10-Q · filed 2016-01-14 | ||||
| 2015-08-31 | $0.42 10-Q · filed 2015-10-15 | ||||
| 2015-02-28 | $0.40 10-Q · filed 2015-04-14 | ||||
| 2014-11-30 | $0.39 10-Q · filed 2015-01-14 | ||||
| 2014-08-31 | $0.38 10-Q · filed 2014-10-15 | ||||
| 2014-02-27 | $0.44 10-Q · filed 2014-04-14 | ||||
| 2013-12-31 | $0.38 10-Q · filed 2014-04-14 | ||||
| 2013-11-30 | $0.40 10-Q · filed 2014-01-14 | ||||
| 2013-08-31 | $0.38 10-Q · filed 2013-10-15 | ||||
| 2013-06-30 | $0.38 10-Q · filed 2014-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |